State Street
MAIA icon

State Street’s MAIA Biotechnology MAIA Stock Holding History

State Street’s Portfolio MAIA Stock Details MAIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$195K Buy
138,950
+63,400
+84% +$117K ﹤0.01% 3894
2025
Q4 		$116K Hold
75,550
– – ﹤0.01% 4021
2025
Q3 		$116K Hold
75,550
– – ﹤0.01% 4024
2025
Q2 		$136K Buy
75,550
+22,300
+42% +$39.9K ﹤0.01% 3919
2025
Q1 		$81.5K Hold
53,250
– – ﹤0.01% 4014
2024
Q4 		$105K Buy
53,250
+18,850
+55% +$45.2K ﹤0.01% 3977
2024
Q3 		$96.7K Hold
34,400
– – ﹤0.01% 3983
2024
Q2 		$118K Buy
34,400
+13,100
+62% +$41.3K ﹤0.01% 3961
2024
Q1 		$46.9K Hold
21,300
– – ﹤0.01% 4173
2023
Q4 		$24.9K Buy
+21,300
New +$34.4K ﹤0.01% 4322

Other funds holding MAIA

SCM
Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
CWM
Centric Wealth Management Chicago, Illinois $501M AUM 15.27% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street's MAIA Position: Q1 2026 in Review

State Street increased its MAIA Biotechnology (MAIA) stake by 84% in Q1 2026, buying an estimated $117K and bringing the position to 138,950 shares worth $195K. The position accounts for ﹤0.01% of the portfolio, ranked #3894.

State Street first reported a position in MAIA in Q4 2023 and has held it in 10 quarters since. 33 funds tracked by Wall St. Rank hold MAIA as of Q1 2026.

  • State Street held 138,950 shares of MAIA Biotechnology worth $195K as of Q1 2026.
  • State Street bought 63,400 MAIA Biotechnology shares in Q1 2026, an estimated $117K.
  • MAIA Biotechnology made up ﹤0.01% of State Street's portfolio in Q1 2026, its #3894 holding.
  • State Street first reported a position in MAIA Biotechnology in Q4 2023 and has held it in 10 quarters since.
  • 33 funds tracked by Wall St. Rank held MAIA Biotechnology as of Q1 2026.

Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.